/
BDX
$183.02+$1.05 (+0.58%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$50.0B
272M shares
52-week range
$140.11 – $213.08
59% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
CS
Change$-66.59
Becton, Dickinson and Co.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
www.bd.com- Employees
- 72,000
- IPO / List date
- Sep 25, 1963
- HQ
- FRANKLIN LAKES, NJ
Held by traders on TradeandTell
No one on the platform currently holds BDX.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-06-30 | 271,391 | $46.7M |
| Bridgewater Associatesas of 2026-03-31 | 9,496 | $1.5M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 2.29% ($4.20/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-09-09 | $1.0500 | 2026-09-30 |
| 2026-06-09 | $1.0500 | 2026-06-30 |
| 2026-03-10 | $1.0500 | 2026-03-31 |
| 2025-12-08 | $1.0500 | 2025-12-31 |
| 2025-09-08 | $1.0400 | 2025-09-30 |
| 2025-06-09 | $1.0400 | 2025-06-30 |
| 2025-03-10 | $1.0400 | 2025-03-31 |
| 2024-12-09 | $1.0400 | 2024-12-31 |
| 2024-09-09 | $0.9500 | 2024-09-30 |
| 2024-06-10 | $0.9500 | 2024-06-28 |
Recent trades on TradeandTell
No one on the platform has traded BDX yet.
